Literature DB >> 11472032

Laparoscopic pancreatic surgery in patients with neuroendocrine tumours: indications and limits.

L Fernández-Cruz1, M Herrera, A Sáenz, J P Pantoja, E Astudillo, M Sierra.   

Abstract

Laparoscopic pancreatic procedures are still at an evaluation stage with regard to their indications and techniques. Between January 1998 and December 2000, 13 patients with endocrine pancreatic tumours - 11 insulinomas and 2 non-functioning tumours-underwent laparoscopic surgery, laparoscopic ultrasonography being used in all the patients. Enucleation was performed in five patients. The operative time was 2-3 hours. Distal pancreatectomy was performed in six patients with insulinomas, and spleen preservation with intact splenic vessels was feasible in five. Splenectomy was necessary in one patient for technical reasons. Laparoscopic distal pancreatectomy with splenic vessel preservation was performed in two patients with a large (6 and 8 cm) non-functioning tumour. The mean operative time for all the patients undergoing distal pancreatectomy was 4 hours, ranging from 3 to 5 hours. A pancreatic fistula occurred in three patients after tumour enucleation and in two patients after distal pancreatectomy; the mean hospital stay for all patients was 5 days. Enucleation guided by laparoscopic ultrasonography thus allows safe tumour dissection and excision, laparoscopic distal pancreatectomy also being feasible and safe. Splenic salvage with splenic vessel preservation is technically possible. The laparoscopic approach allows a shorter hospital stay and an earlier return to normal activities. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11472032     DOI: 10.1053/beem.2001.0133

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  19 in total

1.  Clinical outcomes compared between laparoscopic and open distal pancreatectomy.

Authors:  B W Eom; J-Y Jang; S E Lee; H-S Han; Y-S Yoon; S-W Kim
Journal:  Surg Endosc       Date:  2007-11-20       Impact factor: 4.584

2.  National disparities in minimally invasive surgery for pancreatic tumors.

Authors:  Emmanuel Gabriel; Pragatheeshwar Thirunavukarasu; Kristopher Attwood; Steven J Nurkin
Journal:  Surg Endosc       Date:  2016-07-13       Impact factor: 4.584

3.  Laparoscopic strategies for resection of insulinomas.

Authors:  Laureano Fernández-Cruz; Gleydson Cesar-Borges
Journal:  J Gastrointest Surg       Date:  2006-05       Impact factor: 3.452

4.  Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).

Authors:  Yassar M Hashim; Kathryn M Trinkaus; David C Linehan; Steven S Strasberg; Ryan C Fields; Dengfeng Cao; William G Hawkins
Journal:  Ann Surg       Date:  2014-02       Impact factor: 12.969

Review 5.  Laparoscopic pancreaticoduodenectomy and distal pancreatectomy: a UK experience and a systematic review of the literature.

Authors:  Basil J Ammori; Georgios D Ayiomamitis
Journal:  Surg Endosc       Date:  2011-02-07       Impact factor: 4.584

6.  Hand-assisted laparoscopic resection of serous cystadenoma of the pancreas.

Authors:  R Doi; D Ito; K Fujimoto; I Komoto; Y Ohta; M Torii; M Imamura
Journal:  Surg Endosc       Date:  2003-11-06       Impact factor: 4.584

Review 7.  Laparoscopic resection of pancreatic neuroendocrine tumors.

Authors:  Abbas Al-Kurd; Katya Chapchay; Simona Grozinsky-Glasberg; Haggi Mazeh
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

8.  Neuroendocrine tumors of the pancreas.

Authors:  Y Van Nieuwenhove; S Vandaele; B Op de Beeck; G Delvaux
Journal:  Surg Endosc       Date:  2003-08-15       Impact factor: 4.584

Review 9.  Surgical treatment of pancreatic insulinomas in the era of laparoscopy.

Authors:  C-Y Lo; W-F Chan; C-M Lo; S-T Fan; P-K-H Tam
Journal:  Surg Endosc       Date:  2004-01-12       Impact factor: 4.584

10.  Laparoscopic enucleation of a nonfunctioning neuroendocrine tumor of the pancreas.

Authors:  Chang Moo Kang; Kwang Gil Lee; Ju Yeon Pyo; Sung Whan Lee; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee; Byong Ro Kim
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.